Bini, C., Marcellusi, A., Mennini, F. S., Ripoli, S., Fioravanti, L., Paly, V. F., Molinari, A., Morelli, P., Krotneva, S. and Li, S. (2024) “Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy”, Global and Regional Health Technology Assessment, 11(1), pp. 248–257. doi: 10.33393/grhta.2024.3167.